Citius Pharmaceuticals Earning Date (CTXR)

USA |NASDAQ |USD

CTXR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 10, 2022 Jun 2022 - - $-0.05
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 10, 2022 Jun 2022 - - $0.00

Citius Pharmaceuticals's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.

CTXR Earnings Date & History Chart

CTXR Earnings & Revenue Forecast

CTXR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 1 $-0.15 $-0.15 $-0.15

CTXR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 0 / 0 $-0.15 $0.31 $0.31

CTXR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 1 $0.00 $0.00 $0.00

CTXR Earnings Date & Revenue History

CTXR Earnings History

|
Show More
Show More

CTXR Revenue History

|
Show More
Show More

Citius Pharmaceuticals Next Earnings Date & Report

CTXR Next Earnings Date & Report Preview: Jun 2022 (FQ)

CTXR's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.

Citius Pharmaceuticals Previous Earnings Dates & Reports

CTXR Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Citius Pharmaceuticals's previous earnings date was May 11, 2022 for its fiscal quarter ended Mar 31, 2022.

CTXR Previous Earnings Date & Report Recap: Sep 2021 (FY)

Citius Pharmaceuticals's previous annual earnings date was Dec 15, 2021 for its fiscal year ended Sep 30, 2021.

CTXR's earnings per share (EPS) was $-0.27, missing the consensus analysts forecast of $-0.25 by 8.00% , and higher than the previous year's EPS (Sep 2020) by -41.30%.

Revenues were $0.00.

The company reported a net income of $-23.05M.

Citius Pharmaceuticals reported a free cash flow of $-64.26M for its fiscal year, compared to $-16.93M a year ago.

The company ended the fiscal year with $855.47K in total debt, an increase of 72.28% compared to the previous year.